Chemoinformaics analysis of Pentadecyl 2-bromoacetate
| Molecular Weight | 349.353 | nRot | 15 |
| Heavy Atom Molecular Weight | 316.089 | nRig | 2 |
| Exact Molecular Weight | 348.166 | nRing | 0 |
| Solubility: LogS | -2.925 | nHRing | 0 |
| Solubility: LogP | 2.926 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 33 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 55.0482 |
| nHD | 0 | BPOL | 37.0898 |
| QED | 0.335 |
| Synth | 2.152 |
| Natural Product Likeliness | 0.812 |
| NR-PPAR-gamma | 0.014 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.366 |
| MDCK | 0.0000332 |
| BBB | 0.996 |
| PPB | 0.779707 |
| VDSS | 0.764 |
| FU | 0.381392 |
| CYP1A2-inh | 0.954 |
| CYP1A2-sub | 0.44 |
| CYP2c19-inh | 0.707 |
| CYP2c19-sub | 0.619 |
| CYP2c9-inh | 0.188 |
| CYP2c9-sub | 0.79 |
| CYP2d6-inh | 0.061 |
| CYP2d6-sub | 0.515 |
| CYP3a4-inh | 0.236 |
| CYP3a4-sub | 0.229 |
| CL | 11.652 |
| T12 | 0.835 |
| hERG | 0.039 |
| Ames | 0.015 |
| ROA | 0.215 |
| SkinSen | 0.937 |
| Carcinogencity | 0.37 |
| EI | 0.989 |
| Respiratory | 0.227 |
| NR-Aromatase | 0.014 |
| Antiviral | Yes |
| Prediction | 0.584327 |